Sudhir Agrawal
President and Founder
Arnay Sciences
Rowshon Alam, Ph.D.
Senior Director, Head of Process Chemistry
Prime Medicine
Shalini Andersson, PhD
Vice President of Oligonucleotide Discovery
AstraZeneca
Hiroaki Asai
CEO
GlyTech, Inc.
Andrew Bellinger, MD, PhD
Chief Scientific Officer
Verve Therapeutics
Michael Byrne, Ph.D.
Vice President, In Vivo and CNS Biology
Wave Life Sciences
Brian Cafferty, PhD
Director
Beam Therapeutics
Hwanho Choi, M.D., Ph.D.
CEO and Founder
Quantum Intelligence Corporation
Loic Cornelissen, PhD
Associate Director, Business Development
PolyPeptide Group
Andreas Czech, PhD
Associate Director RNA Analytics
BioNTech SE
Ratmir Derda, PhD
Founder and CSO, 48Hour Discovery and Associate Professor, Department of Chemistry
University of Alberta
Alaric Desmarchelier, PhD
Business Development Manager - Peptides
Almac Group
Wendy Hartsock, PhD
Director of Strategic Partnerships
Aralez Bio
Frank Jaschinski, Ph.D.
Secarna Pharmaceuticals
Ekkehard Leberer, PhD
Scientific Advisor
Neuway Pharma
Kunwoo Lee, PhD
Chief Executive Officer
GenEdit
Xiaocen (Chris) Li, PhD
Supervisor
LGC Axolabs
Jennifer Lockridge, PhD
VP, Dicerna TRU Early Development
Novo Nordisk
Danith Ly, Ph.D.
Professor of Chemistry
Carnegie Mellon University
Jody Mason, PhD
Professor of Biochemistry
University of Bath
Michael McGinley
Director, Global Applications
Phenomenex
Zdravka Medarova, PhD
Founder and Chief Technology Officer
TransCode Therapeutics
Aditi Mehta, PhD
Associate Director, Head of mRNA Process & Deliver
Merck KGaA
Brett Monia, PhD
Ionis Pharmaceuticals
Bruce Morimoto, PhD
Vice President, Drug Development
Alto Neuroscience
Juergen Mueller, PhD
Vice President of Commercial Operations
Jayaprakash Nair, PhD
Vice President, Research, Chemistry and Delivery Science
Alnylam Pharmaceuticals
Yoshitaka Nemoto
Vice President R&D
PeptiStar
Mehran Nikan, Ph.D.
Research Fellow
Ionis Pharmaceuticals Inc
Yuji Nishiuchi, Ph.D.
Director of Research and Development
Henrik Oerum, PhD
Founder and Chief Scientific Officer
CiVi Biopharma Inc.
Kousaku Ohinata, Ph.D.
Founder and Scientific Advisor
Viage Therapeutics
Yutaka Okada
President and Representative Director
Alnylam Japan KK
Emily Place, PhD
Senior Consultant
Aclairo Pharmaceutical Development Group
Christian Plank, PhD
Chief Technology Officer
Ethris GmbH
Spenser Pruett
Scientist II, Process Development
Nitto Avecia
Leo Qian, PhD
Co-Founder and Vice President, Discovery Research
Entrada Therapeutics
Shobha Ravipaty, PhD
Stoke Therapeutics
El Djouhar Rekai, PhD
Head of Process Development & Manufacturing Life cycle Management
Eriks Rozners, Ph.D.
Professor and Chair of Chemistry Department
Binghamton University
Thomas Rupp
Owner & Principal
Thomas Rupp Consulting, Germany
Eike-Fabian Sachs, PhD
Head of Development Frankfurt
CordenPharma International GmbH
Daniel Samson, PhD
Vice President, Head Oligonucleotides
Bachem AG
Masato Sanosaka, PhD
Group Leader of Research & Process Development
Ajinomoto Biopharma Services
Mitsuaki Sekiguchi, Ph.D.
Principal Scientist, Biopharmaceutical Research Di
Shionogi & Co., Ltd.
Dewey Sutton, PhD
Research and Development Supervisor
AmbioPharm
Ying Tam, Ph.D.
Acuitas Therapeutics
Meritxell Teixido, PhD
CEO and CSO
Gate2Brain
Juerg Tschopp, PhD
Principal Scientist
Stratum Medical Corporation
Blake Unterreiner
Associate Vice President, Business Development & Customer Relations
Agilent Technologies
Alexander Vinogradov, Ph.D.
Project Assistant Professor
The University of Tokyo
Elizabeth Wagner, Ph.D.
Director, Biology
Jimmy Weterings, PhD
Senior Director, Head of Technology Development
Sirnaomics
Dieter Willbold, Ph.D.
Director and Full Professor
Forschungszentrum Julich
Pengyu Xu, Ph.D.
SynCrest Inc.
Syunsuke Yamamoto
Associate Director
Takeda Pharmaceutical Company
Ed Yaworski
Genevant Sciences Corp
Kate Zhang, Ph.D.
Hopewell Therapeutics
Lulu Zhang, PhD
Field Application Scientist
Thermo Fisher Scientific
